Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Osteomalacia
MeSH D010018 - osteomalacia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012279:
Rickets
30 Companies
14 Drugs
$
Success rate
D010018:
Osteomalacia
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Kyowa Kirin
Burosumab
Crysvita
2018-02-19
Clinical Trials
Historical Success Rate
Phase 1
100
%
2/2
Phase 2
0
%
0/4
Phase 3
0
%
0/0
Approved:
0
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Kyowa Kirin
Burosumab
,
Burosumab-twza
,
Q2w
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use